Pfizer

Pfizer Market capitalization

The The market capitalization of Pfizer (PFIZER.NS) as of Nov 12, 2026 is 220.63 B INR. In the previous year, The market capitalization was 220.63 B INR — a change of 0.00% (lower).

Market capitalization

220.63 BINR

YoY

0.00%

Last updated:

In 2026, Pfizer's market cap stood at 220.63 B INR, a 0.00% increase from the 220.63 B INR market cap in the previous year.

The Pfizer Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2019
220.63 B INR
Jan 1, 2020
220.63 B INR
Jan 1, 2021
220.63 B INR
Jan 1, 2022
220.63 B INR
Jan 1, 2023
220.63 B INR
Jan 1, 2024
220.63 B INR
Jan 1, 2025
220.63 B INR
Jan 1, 2026
220.63 B INR
The Pfizer Market capitalization history
YEARMarket capitalizationYoY
220.63 BINR0.00%
220.63 BINR0.00%
220.63 BINR0.00%
220.63 BINR0.00%
220.63 BINR0.00%
220.63 BINR0.00%
220.63 BINR0.00%
220.63 BINR0.00%
220.63 BINR0.00%
220.63 BINR0.00%
220.63 BINR0.00%
220.63 BINR0.00%
220.63 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pfizer Stock analysis

What does Pfizer do? Pfizer Ltd is a global biopharmaceutical company based in New York City, USA. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhart, and has achieved numerous milestones in the pharmaceutical industry during its 170-year history. Pfizer's business model is based on the research, development, production, and distribution of innovative drugs and vaccines for a variety of diseases. With a diverse portfolio of products, the company's range extends from drugs for cancer, inflammation, and immunology to neurological and cardiology conditions. Pfizer is a global leader in the development of cancer drugs and has achieved groundbreaking research successes in recent years. Key divisions of the company include oncology, pain management, cardiology, and neurology. Pfizer places great emphasis on putting patients and their needs at the center and works closely with medical professionals, patient groups, and authorities to ensure the best possible patient care. Pfizer is a leading provider of vaccines and has achieved significant breakthroughs in the development of COVID-19 vaccines in recent years. In December 2020, the company was one of the first worldwide to bring a vaccine against the coronavirus to market, making a significant contribution to the fight against the pandemic. In addition to drug research and development, Pfizer is also heavily involved in corporate social responsibility. The company is committed to sustainable development and continuously works to reduce its carbon footprint. The Pfizer Foundation also supports numerous nonprofit organizations and projects in the areas of health, education, and environmental protection. Among Pfizer's most well-known products are medications such as Viagra, Lipitor, and Lyrica, as well as the COVID-19 vaccine Comirnaty. Pfizer has offices in over 150 countries and employs over 90,000 people worldwide. Like any global company, Pfizer faces challenges. The company is often criticized for high drug prices and the availability of medications in developing countries. However, Pfizer actively advocates for access to affordable healthcare and delivers drugs and vaccines to all regions of the world. Overall, Pfizer is a company of great importance in the global healthcare industry. Through its research and development of innovative drugs and vaccines, the company contributes to improving the quality of life for millions of people worldwide. Pfizer is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Pfizer's Market Capitalization

Pfizer's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Pfizer's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Pfizer's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Pfizer’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Pfizer stock

The market capitalization of Pfizer is 220.63 B INR in 2026.

The market capitalization of Pfizer changed from 220.63 B INR to 220.63 B INR, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Pfizer since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's INR, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' INR varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Pfizer with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Pfizer

All Key Metrics — Pfizer